Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B
Article first published online: 17 FEB 2005
Journal of Viral Hepatitis
Volume 12, Issue 2, pages 199–206, March 2005
How to Cite
Papatheodoridis, G. V., Petraki, K., Cholongitas, E., Kanta, E., Ketikoglou, I. and Manesis, E. K. (2005), Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B. Journal of Viral Hepatitis, 12: 199–206. doi: 10.1111/j.1365-2893.2005.00582.x
- Issue published online: 17 FEB 2005
- Article first published online: 17 FEB 2005
- Received February 2004; accepted for publication May 2004
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!